cell-therapy

Documents about cell-therapy

• Somatic Cell Therapy: A Genetic Rescue for a Tattered Immune System?#107353PhilArchive
• Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma#140980ClinicalTrials.gov
• CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS#195325ClinicalTrials.gov
• Erythrocyte patch for enhanced B cell depletion therapy.#214059NCBI PubMed Central
• Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial#274667IRIS
• A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.#398308ClinicalTrials.gov
• Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease#833937ClinicalTrials.gov
• Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck#841819ClinicalTrials.gov
• Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery#851036ClinicalTrials.gov
• Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer#836948ClinicalTrials.gov
• Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma#180397ClinicalTrials.gov
• Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)#67862ClinicalTrials.gov
• Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.#143554ClinicalTrials.gov
• Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer#160349ClinicalTrials.gov
• Genetic Engineering of Notch1 Regulatory Elements to Improve CD19 CAR T-cell Proliferation and Persistence#273814Harvard DASH
• Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis#385407OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Chimeric antigen receptor T-cell therapy for rheumatic diseases: from B-cell depletion to immune reset and beyond.#630959NCBI PubMed Central
• Synthetically Reprogramming T Cell Communication to Understand and Engineer Immune Responses#651687eScholarship
• A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma#834704ClinicalTrials.gov
• Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer#849111ClinicalTrials.gov
• Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma#852222ClinicalTrials.gov
• ENDOGENOUS ANTIVIRAL PROPERTIES OF RED BLOOD CELL-DERIVED EXTRACELLULAR VESICLES AND THEIR AUGMENTATION OF ANTIVIRAL OLIGONUCLEOTIDE THERAPY#254781ScholarBank@NUS
• Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy#141093ClinicalTrials.gov
• Autologous Muscle Derived Cells for Female Urinary Sphincter Repair#826760ClinicalTrials.gov
• Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC#859103ClinicalTrials.gov
• The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial#811414ClinicalTrials.gov
• Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS#827115ClinicalTrials.gov
• Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy#840428ClinicalTrials.gov
• Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma#830418ClinicalTrials.gov
• Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease#841368ClinicalTrials.gov
• Repurposing Bromhexine to Suppress Non-Small Cell Lung Cancer Growth by Inhibiting Methylenetetrahydrofolate dehydrogenase 2 - Dataset#196685Figshare
• A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma#343841ClinicalTrials.gov
• Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma#208289ClinicalTrials.gov
• Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration#245367ClinicalTrials.gov
• Dual molecular therapy targeting tumor cell heterogeneity improves therapeutic efficacy in glioblastoma#292618OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Focal radiotherapy improves CAR T cell therapy targeting prostate cancer#417339bioRxiv / medRxiv
• Immune Response Evaluation to Curative Conventional Therapy#633739ClinicalTrials.gov
• Vemurafenib and White Blood Cell Therapy for Advanced Melanoma#668830ClinicalTrials.gov
• Cell-free RNA Signatures Derived from the Tumor Microenvironment Predict Outcomes of CAR-T Therapy in Large B Cell Lymphoma#13920bioRxiv / medRxiv
• Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma#123466ClinicalTrials.gov
• Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy#325258ClinicalTrials.gov
• A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.#356463ClinicalTrials.gov
• IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)#405157ClinicalTrials.gov
• KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors#414486ClinicalTrials.gov
• Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes#429754ClinicalTrials.gov
• Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL#855069ClinicalTrials.gov
• Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery#828229ClinicalTrials.gov
• Chimeric antigen receptor T-cell therapy in systemic lupus erythematosus: From B cell depletion to immune reprogramming#780678Europe PMC
• Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer#845416ClinicalTrials.gov
• Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma#474745ClinicalTrials.gov